Literature DB >> 6143656

Central nervous system regulation of adrenocorticotropin secretion: role of somatostatins.

M R Brown, C Rivier, W Vale.   

Abstract

Somatostatin-28 (SS-28) and desAA1,2,4,5,12,13[D-Trp8]somatostatin (ODT8-SS), but not somatostatin-14, given intracerebroventricularly, but not when given iv, inhibit stress-induced pituitary ACTH and adrenomedullary epinephrine secretion in rats. The elevation of ACTH after tail-suspension stress is totally prevented by iv administration of antisera raised against corticotropin-releasing factor (CRF). SS-28 and ODT8-SS do not inhibit CRF-induced ACTH secretion in vivo or in vitro. These results are consistent with the hypothesis that SS-28 and ODT8-SS prevent stress-induced ACTH secretion by inhibition of CRF release.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6143656     DOI: 10.1210/endo-114-5-1546

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  27 in total

1.  Tissue-specific distribution of cross-linked somatostatin receptor proteins in the rat.

Authors:  C B Srikant; K K Murthy; Y C Patel
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse.

Authors:  Lori M Gorton; Marta G Vuckovic; Nina Vertelkina; Giselle M Petzinger; Michael W Jakowec; Ruth I Wood
Journal:  Behav Brain Res       Date:  2010-05-21       Impact factor: 3.332

3.  Central administration of pan-somatostatin agonist ODT8-SST prevents abdominal surgery-induced inhibition of circulating ghrelin, food intake and gastric emptying in rats.

Authors:  A Stengel; M Goebel-Stengel; L Wang; A Luckey; E Hu; J Rivier; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2011-05-13       Impact factor: 3.598

4.  Central somatostatin receptor 1 activation reverses acute stress-related alterations of gastric and colonic motor function in mice.

Authors:  A Stengel; M Goebel-Stengel; L Wang; M Larauche; J Rivier; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2011-06       Impact factor: 3.598

Review 5.  Somatostatin.

Authors:  S R Bloom; J M Polak
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

Review 6.  The role of somatostatin analogs in Cushing's disease.

Authors:  Joost van der Hoek; Steven W J Lamberts; Leo J Hofland
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

7.  The influence of chronic administration of the serotonin agonist dexfenfluramine on responsiveness to corticotropin releasing hormone and growth hormone-releasing hormone in moderately obese people.

Authors:  M L Drent; H J Adèr; E A van der Veen
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

8.  Somatostatin receptor subtype 5 modifies hypothalamic-pituitary-adrenal axis stress function.

Authors:  Masaaki Yamamoto; Anat Ben-Shlomo; Hiraku Kameda; Hidenori Fukuoka; Nan Deng; Yan Ding; Shlomo Melmed
Journal:  JCI Insight       Date:  2018-10-04

Review 9.  Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes.

Authors:  Andreas Stengel; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2012-12-31       Impact factor: 3.750

10.  Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: a urocortin1-independent mechanism.

Authors:  Raúl Pastor; Carrie S McKinnon; Angela C Scibelli; Sue Burkhart-Kasch; Cheryl Reed; Andrey E Ryabinin; Sarah C Coste; Mary P Stenzel-Poore; Tamara J Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.